In a sweeping procedural shift, U.S. Patent and Trademark Office (USPTO) Director John Squires announced Friday that he will personally make all institution decisions for America Invents Act (AIA) patent reviews — including both merits-based and discretionary determinations — effectively ending the Patent Trial and Appeal Board’s (PTAB) decade-long control over those decisions.
The change, which takes effect October 20, represents the most significant overhaul of the AIA review process since its creation in 2012. It restores the authority that Congress explicitly granted to the USPTO director under the statute but which had been delegated to the PTAB for practical reasons.
“Reclaiming the Director’s Statutory Role”
In an open letter to “colleagues, inventors, and Americans,” Squires said the decision aims to restore fairness, predictability, and public confidence in the patent system:
“The USPTO can serve the public interest only by maintaining a patent system that is fair, predictable, and respected,” Squires wrote. “Returning institution authority to the director bolsters our mission because it restores the statutory framework mandated by Congress in the America Invents Act.”
Under the new process, Squires will consult with at least three PTAB judges before deciding whether to institute inter partes reviews (IPRs) or post-grant reviews (PGRs). He said his decisions will typically be brief “summary notices” declaring whether review is appropriate.
When a petition raises “novel or important factual or legal issues,” Squires may issue a more detailed opinion. In complex cases — such as those involving claim construction, priority analysis, or real-party-in-interest determinations — he may refer specific issues to PTAB judges for detailed analysis before issuing a final institution decision.
We are The People's Media. USA Herald covers everything from breaking news to investigative journalism. We also report on politics on the State and National levels.
